First Human Clinical Trial Proves TruZen® CBD Formula with Patented VESIsorb® Technology Achieves 360% greater Bioavailability of β-caryophyllene (BCP)
Pittsburgh, PA (PRWEB) November 30, 2022 -- Nutraceuticals Innovator TruZen® Health has announced the results of a first ever human-based clinical trial,
Michael Lioon Drug Administration Health Vp Operations Innovator Truzen Clinical Trial Study Novel Self Emulsifying Drug Delivery System
Source: prweb.com